Boxed warning (black box) drugs on Facebook: ONFI (Link): disabled comments, actively posting updates Tysabri (Link): allowed comments, actively posting Afrezza (Link): allowed comments (as of May 8, 2017), page went live on ~April 21, 2017 Tasigna (Link): disabled comments, actively posting updates Quillivant XR & QuilliChew ER (Link): disabled comments, not actively posting Linzess (Link): disabled comments, not Continue reading
Pharma companies have been shying away from YouTube for a long time, despite its ability to educate and influence a qualified audience (YouTube is the #2 most popular search engine, after all). Recently, the best practices for a YouTube presence for pharmaceutical brands have become: Non-branded channel name, mixed in with: Branded and creative videos Scrolling important safety Continue reading
This is a list of active pharma resources, scrubbed monthly. If you have suggestions, please fill out the form below. Above MS (supporting multiple Biogen treatment options: Tecfidera, Plegridy, Tysarbi, and Avonex) Crohn’s and Colitis (AbbVie, primarily supporting Humira’s Crohn’s indication) Crohn’s and Me (UCB) MS Lifelines (Rebif) Her Emdometriosis Reality (AbbVie, HCPs) ReimagineMyself (light Tecfidera Continue reading